ADAG · Adagene Inc ADR
United States · RS rating 24 · As of 2026-10-14
| Price | 2.29 USD |
|---|---|
| 1-day change | -6.9% |
| RS rating (overall / 1M / 3M / 12M) | 24 / 10 / 9 / 74 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 27 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +52.1% |
| Market cap (USD) | $247.1M |